NCT04805606View on ClinicalTrials.gov

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

December 24, 2021

Study Completion Date

December 24, 2021

Conditions
Alopecia
Interventions
DRUG

CKD-843 A

Single Dose

DRUG

CKD-843 B

Single Dose

DRUG

CKD-843-R

QD, PO

Trial Locations (1)

120-752

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04805606 - A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 | Biotech Hunter | Biotech Hunter